Radio and PodcastRadio and PodcastLive Radio & Podcasts
S17 Ep64: FDA Approval Insights: First-Line Sacituzumab Govitecan Plus Pembrolizumab for PD-L1+ TNBC: With Sara M. Tolaney, MD, MPH artwork
Science & Medicine

S17 Ep64: FDA Approval Insights: First-Line Sacituzumab Govitecan Plus Pembrolizumab for PD-L1+ TNBC: With Sara M. Tolaney, MD, MPH

OncLive® On Air by Audioboom

Jul 28, 20265:38Science & Medicine

In today’s episode, we spoke with Sara M. Tolaney, MD, MPH, about the FDA approval of sacituzumab govitecan plus pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the first-lin...

About This Episode

S17 Ep64: FDA Approval Insights: First-Line Sacituzumab Govitecan Plus Pembrolizumab for PD-L1+ TNBC: With Sara M. Tolaney, MD, MPH is an episode from OncLive® On Air by Audioboom. In today’s episode, we spoke with Sara M. Tolaney, MD, MPH,...

Podcast

This episode belongs to OncLive® On Air.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 28, 2026, 5:38 long, audio available.

Related Episodes

Continue listening to more episodes from OncLive® On Air.